DV
Dividend Vision

MSGR — Direxion mRNA ETF

No longer trading. This fund has been liquidated; the figures below are frozen at its final trading day.

Direxion mRNA ETF (MSGR)

Direxion mRNA ETF provides equity exposure to companies involved in messenger RNA technology and therapeutics development. The fund focuses on the specialized biotech sector centered on mRNA-based treatments and vaccines rather than traditional dividend-paying stocks. This ETF appeals primarily to growth-oriented investors seeking exposure to innovative biotechnology rather than income-focused investors, as mRNA companies typically prioritize reinvestment and research over dividend distributions.

MSGR key facts

Issuer
Direxion
Asset type
ETF
Asset class
Equity
Last close
$13.91
Average volume
0.0